Q3 2025 Earnings Call November 6, 2025 5:00 PM ESTCompany ParticipantsRyan Schaffer - CFO & DirectorNiki WallrothDavid Barrett ...
Gyre Therapeutics ("Gyre") (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, ...
TipRanks on MSN
Expensify Reports Q3 2025 Financial Results and AI Upgrade
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals ...
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence ...
Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, today announced its operating and financial results ...
Expensify, the easiest way to manage expenses, corporate cards, and travel, today announced the next evolution of Concierge, its embedded support system, now transformed into a full-service expense ...
DHL is using Celonis' process intelligence platform combined with generative AI to automatically screen 100% of employee ...
Please note that the limited information that follows in this press release is not adequate to make an informed investment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback